ATLASATLAS fair value
CHF 448.96
Below fair value · 10% discount
Range: CHF 365–CHF 817Fair valuePrice
Roche (RO.SW)
Roche stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - General · SIX Swiss Exchange · Switzerland
CHF 405.40▲ +0.50%
Prices as of Oct 27, 2026 · CHF
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Roche in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Roche
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Roche's fair value at about CHF 448.96 per share (reasonable range: CHF 364.54 to CHF 817.08). At CHF 405.40, the stock trades 10% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Roche a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 392.21 and CHF 422.33; in 9 out of 10, between CHF 367.31 and CHF 450.95. Estimated annual volatility is 21%.
Price, last 12 months (weekly close)
Key numbers
- P/E ratio
- 25.1
- Dividend yield
- 2.54%
- 52-week high
- CHF 406.00
- 52-week low
- CHF 270.80
- Revenue (12 months)
- CHF 63.0B
- Gross margin
- 74.2%
- Operating margin
- 36.2%
- Net margin
- 19.6%
- Beta
- 0.33
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Roche sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks RO.SW has traded between CHF 270.80 and CHF 406.00. Today it is at its high and 50% above its low.
On the business: net margin is 19.6%; it trades at 25.1 times earnings.
Its beta is 0.33: it tends to move less than the market.
About the company
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Want to see everything about Roche?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Roche (RO.SW) fair value?
About CHF 448.96 per share according to ATLAS (reasonable range: CHF 364.54 to CHF 817.08). With the stock at CHF 405.40, it is 10% below it.
What is the chance RO.SW goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, RO.SW ends the month between CHF 392.21 and CHF 422.33.
How big is Roche and what is its P/E ratio?
Its price-to-earnings (P/E) ratio is 25.1: you pay CHF 25.1 for each CHF 1.00 of yearly earnings.
Does Roche pay a dividend?
Yes. RO.SW's current dividend yield is 2.54% at today's price (CHF 405.40).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer